Virco BVBA has announced that their HIV resistance testing product, virco®TYPE HIV-1, has achieved CE-Marking approval. virco®TYPE HIV-1 is the only bioinformatic diagnostic device of its kind to carry CE-Marking in the HIV market. The CE-Marking indicates that virco®TYPE HIV-1 is a medical...
Roche Molecular Diagnostics (SIX: RO, ROG: OTCQX: RHHBY) announced that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 is the first...
Publishing in PLoS Pathogens, researchers at from the Kimmel Cancer Center at Jefferson have found a novel mechanism by which drugs block HIV-1 from entering host cells. Cellular invasion by HIV-1 requires the concerted action of two proteins on the viral surface: gp120 and gp41. The function...